Trial intelligence / Profile preview

EASE: Losartan/HCTZ vs Valsartan/HCTZ in Essential Hypertension

NCT00546754Phase 3Completed

Sponsor
Organon & Co.
Start
May 2007
Primary completion
Apr 2009
Modality
Small Molecules
01

Overview

A Phase 3 trial of losartan, hydrochlorothiazide in essential hypertension, sponsored by Organon & Co.. Started May 2007; status: completed.

02

Drugs

losartanhydrochlorothiazide
03

Conditions

essential hypertension

Beyond the preview

Go deeper on NCT00546754.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00546754.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call